Your browser doesn't support javascript.
COVID-19 and immunomodulation treatment for women with reproductive failures.
Kwak-Kim, Joanne; Ota, Kuniaki; Sung, Nayoung; Huang, Changsheng; Alsubki, Lujain; Lee, Sungki; Han, Jae Won; Han, Aera; Yang, Xiuhua; Saab, Wael; Derbala, Youssef; Wang, Wen-Juan; He, Qiaohua; Liao, Aihua; Takahashi, Toshifumi; Cavalcante, Marcelo Borges; Barini, Ricardo; Bao, Shihua; Fukui, Atsushi; Lédée, Nathalie; Coulam, Carolyn.
  • Kwak-Kim J; Reproductive Medicine and Immunology, Obstetrics and Gynecology, Clinical Sciences Department, Center for Cancer Cell Biology, Immunology and Infection, Chicago Medical School, Rosalind Franklin University of Medicine and Science, 830 West End Court, Vernon Hills, IL, 60061, USA. Electronic address:
  • Ota K; Fukushima Medical Center for Children and Women, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan.
  • Sung N; Reproductive Medicine and Immunology, Obstetrics and Gynecology, Clinical Sciences Department, Center for Cancer Cell Biology, Immunology and Infection, Chicago Medical School, Rosalind Franklin University of Medicine and Science, 830 West End Court, Vernon Hills, IL, 60061, USA.
  • Huang C; Reproductive Medicine and Immunology, Obstetrics and Gynecology, Clinical Sciences Department, Center for Cancer Cell Biology, Immunology and Infection, Chicago Medical School, Rosalind Franklin University of Medicine and Science, 830 West End Court, Vernon Hills, IL, 60061, USA; Traditional Chinese
  • Alsubki L; Reproductive Medicine and Immunology, Obstetrics and Gynecology, Clinical Sciences Department, Center for Cancer Cell Biology, Immunology and Infection, Chicago Medical School, Rosalind Franklin University of Medicine and Science, 830 West End Court, Vernon Hills, IL, 60061, USA; Department of Obste
  • Lee S; Department of Obstetrics and Gynecology, Myuonggok Medical Research Center, Konyang University College of Medicine, Daejeon, South Korea.
  • Han JW; Department of Obstetrics and Gynecology, Myuonggok Medical Research Center, Konyang University College of Medicine, Daejeon, South Korea.
  • Han A; Department of Obstetrics and Gynecology, MizMedi Hospital, Seoul, South Korea.
  • Yang X; Department of Obstetrics, The First Hospital of China Medical University, Shenyang, China.
  • Saab W; The Centre for Reproductive & Genetic Health, 230-232 Great Portland St, Fitzrovia, London W1W 5QS, UK.
  • Derbala Y; Obstetrics and Gynecology, Beaumont Hospital, Dearborn, Grosse Pointe, MI, USA.
  • Wang WJ; Reproduction Medical Center, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, 264000, China.
  • He Q; Department of Reproductive Medicine Center, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital of Henan University, Zhengzhou, Henan, 450003, China.
  • Liao A; Institute of Reproductive Health, Center for Reproductive Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
  • Takahashi T; Fukushima Medical Center for Children and Women, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan.
  • Cavalcante MB; Department of Obstetrics and Gynecology, Fortaleza University (UNIFOR), Fortaleza, CE, Brazil; CONCEPTUS - Reproductive Medicine, Fortaleza, CE, Brazil.
  • Barini R; Department of Obstetrics and Gynecology, Campinas University (UNICAMP), Campinas, SP, Brazil.
  • Bao S; Department of Reproductive Immunology, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, 201204, China.
  • Fukui A; Department of Obstetrics and Gynecology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan.
  • Lédée N; MatriceLAB Innove, Pépinière Paris Santé Cochin, Hôpital Cochin, 29 rue du faubourg St Jacques, 75014 Paris, France; Centre d'assistance médicale à la procréation, Hôpital des Bluets, 4 rue Lasson, 75012, Paris, France.
  • Coulam C; Clinical Immunology Laboratory, Rosalind Franklin University of Medicine and Science, North Chicago, 60064, IL, USA.
J Reprod Immunol ; 141: 103168, 2020 09.
Article in English | MEDLINE | ID: covidwho-597787
ABSTRACT
COVID-19 pandemic is affecting various areas of health care, including human reproduction. Many women with reproductive failures, during the peri-implantation period and pregnancy, are on the immunotherapy using immune modulators and immunosuppressant due to underlying autoimmune diseases, cellular immune dysfunction, and rheumatic conditions. Many questions have been raised for women with immunotherapy during the COVID-19 pandemic, including infection susceptibility, how to manage women with an increased risk of and active COVID-19 infection. SARS-CoV-2 is a novel virus, and not enough information exists. Yet, we aim to review the data from previous coronavirus outbreaks and current COVID-19 and provide interim guidelines for immunotherapy in women with reproductive failures.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Pregnancy Complications / Coronavirus Infections / Betacoronavirus / Immunotherapy Type of study: Prognostic study Limits: Female / Humans / Pregnancy Language: English Journal: J Reprod Immunol Year: 2020 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Pregnancy Complications / Coronavirus Infections / Betacoronavirus / Immunotherapy Type of study: Prognostic study Limits: Female / Humans / Pregnancy Language: English Journal: J Reprod Immunol Year: 2020 Document Type: Article